State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements.
Silwal A, Talbert J, Bohler RM, Kelsch J, Cook C, Blevins D, Gallivan M, Hunt T, Hatcher SM, Thomas CP, Williams S, Fanucchi L, Lofwall MR.
Silwal A, et al. Among authors: talbert j.
Drug Alcohol Depend Rep. 2023 May 2;7:100164. doi: 10.1016/j.dadr.2023.100164. eCollection 2023 Jun.
Drug Alcohol Depend Rep. 2023.
PMID: 37234704
Free PMC article.